Crk-associated substrate lymphocyte type regulates transforming growth factor-β signaling by inhibiting Smad6 and Smad7

被引:19
|
作者
Inamoto, S.
Iwata, S.
Inamoto, T.
Nomura, S.
Sasaki, T.
Urasaki, Y.
Hosono, O.
Kawasaki, H.
Tanaka, H.
Dang, N. H.
Morimoto, C.
机构
[1] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Clin Immunol,Minato Ku, Tokyo 1088639, Japan
[2] Osaka Med Coll, Dept Med, Osaka, Japan
[3] Nevada Canc Inst, Dept Hematol Malignancies, Las Vegas, NV USA
关键词
Cas-L; Smad6; Smad7; TGF-beta; cancer;
D O I
10.1038/sj.onc.1209848
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Crk-associated substrate lymphocyte type (Cas-L) is a 105 kDa docking protein with diverse functional properties, including regulation of cell division, proliferation, migration and adhesion. Cas-L is also involved in beta 1 integrin- or antigen receptor-mediated signaling in B and T cells. In the present study, we demonstrate that Cas-L potentiates transforming growth factor-beta (TGF-beta) signaling pathway by interacting with Smad6 and Smad7. Immunoprecipitation experiments reveal that single domain deletion of full-length Cas-L completely abolishes its docking function with Smad6 and Smad7, suggesting that the natural structure of Cas-L is necessary for its association with Smad6 and Smad7. On the other hand, both N-terminal and C-terminal deletion mutants of Smad6 and Smad7 still retain their docking ability to Cas-L, suggesting that Smad6 and Smad7 possess several binding motifs to Cas-L. Moreover, Cas-L interaction with Mad-homology (MH)2 domain, but not with MH1 domain of Smad6 or Smad7, ameliorates TGF-beta-induced signaling pathway. Finally, depletion of Cas-L by small-interfering RNA oligo attenuates TGF-beta-induced growth inhibition of Huh-7 cells, with a concomitant reduction in phosphorylation of Smad2 and Smad3. These results strongly suggest that Cas-L is a potential regulator of TGF-beta signaling pathway.
引用
收藏
页码:893 / 904
页数:12
相关论文
共 50 条
  • [41] Smad7 mediates growth suppression induced by transforming growth factor-β in human prostate stromal cells.
    Obara, K
    Bilim, V
    Kobayashi, K
    Tomita, Y
    Hara, N
    Kasahara, T
    Arai, K
    Takahashi, K
    JOURNAL OF UROLOGY, 2002, 167 (04): : 218 - 219
  • [42] Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor β
    von Gersdorff, G
    Susztak, K
    Rezvani, F
    Bitzer, M
    Liang, D
    Böttinger, EP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (15) : 11320 - 11326
  • [43] Ectopic expression of Smad7 inhibits transforming growth factor-β responses in vascular smooth muscle cells
    Kato, S
    Ueda, S
    Tamaki, K
    Fujii, M
    Miyazono, K
    ten Dijke, P
    Morimatsu, M
    Okuda, S
    LIFE SCIENCES, 2001, 69 (22) : 2641 - 2652
  • [44] SMAD7 IS A KEY MODULATOR OF GROWTH FACTOR SIGNALING IN GRANULOSA CELLS
    McGee, E.
    Quezada, M.
    Wang, J.
    FERTILITY AND STERILITY, 2011, 96 (03) : S127 - S127
  • [45] Signaling of transforming growth factor-β family members through Smad proteins
    Itoh, S
    Itoh, F
    Goumans, MJ
    ten Dijke, P
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (24): : 6954 - 6967
  • [46] Transforming growth factor β1 induces nuclear export of inhibitory Smad7
    Itoh, S
    Landström, M
    Hermansson, A
    Itoh, F
    Heldin, CH
    Heldin, NE
    ten Dijke, P
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (44) : 29195 - 29201
  • [47] Hsa-miR-186-5p regulates TGFβ signaling pathway through expression suppression of SMAD6 and SMAD7 genes in colorectal cancer
    Bayat, Zahra
    Ghaemi, Zahra
    Behmanesh, Mehrdad
    Soltani, Bahram M.
    BIOLOGICAL CHEMISTRY, 2021, 402 (04) : 469 - 480
  • [48] Mutational analysis of TGF-β type II receptor, Smad2, Smad3, Smad4, Smad6 and Smad7 genes in colorectal cancer
    Fukushima, T
    Mashiko, M
    Takita, K
    Otake, T
    Endo, Y
    Sekikawa, K
    Takenoshita, S
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2003, 22 (02) : 315 - 320
  • [49] Interdependent SMAD and JNK signaling in transforming growth factor-β-mediated transcription
    Engel, ME
    McDonnell, MA
    Law, BK
    Moses, HL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (52) : 37413 - 37420
  • [50] Phosphorylation of Smad7 at Ser-249 does not interfere with its inhibitory role in transforming growth factor-β-dependent signaling but affects Smad7-dependent transcriptional activation
    Pulaski, L
    Landström, M
    Heldin, CH
    Souchelnytskyi, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (17) : 14344 - 14349